SLC7A11 and cancer: Nevertheless, disulfiram‐copper exceptionally inhibited the activation of NRF2 induced by sulfasalazine (a ferroptosis inducer inhibiting system xc−) and the expression of its downstream antioxidant molecules such as SLC7A11, thereby exerting a synergistic effect in lung adenocarcinoma.[141] Similar inhibitory effects have also been identified in acute myeloid leukemia.[142] This might be ascribed to the specificity of cancer types or the context of experimental treatment.